BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 18, 2014
View Archived Issues
Cleave Biosciences presents new lead compound CB-5083 for tumors
Read More
Phase II evaluation of an AT2 receptor antagonist for postherpetic neuralgia
Read More
TK-001, TK-002 and TK-003 to be outlicensed after phase Ib
Read More
LUTE and VERSE study data show efficacy for lebrikizumab in uncontrolled asthma
Read More
A first-in-class melanocortin MC4 receptor agonist for the treatment of sexual dysfunction
Read More
NDA for lubiprostone liquid formulation will not be filed this year
Read More
Five Prime Therapeutics and BMS sign collaboration for immuno-oncology therapies
Read More
Votrient receives an additional indication approval in Japan
Read More
Merck & Co. designs new agents for diabetes and other disorders
Read More
Amgen reports topline results from the phase III TESLA trial
Read More
Novel, selective 5-HT5A receptor antagonist as a potential treatment for schizophrenia
Read More
Allermist approved in Japan for pediatric allergic rhinitis
Read More
Treventis discloses novel agents for Alzheimer's disease
Read More
Boehringer Ingelheim synthesizes novel neutrophil elastase inhibitors
Read More
NVS-CRF38, a new CRF1 receptor antagonist, described by Novartis
Read More
Theracos reports data from phase II study of THR-1442 in type 2 diabetes
Read More
Researchers at Alios BioPharma present novel antiviral agents
Read More
NeoStem reports on fourth data safety monitoring board review of PreSERVE AMI trial
Read More
uniQure and Chiesi Farmaceutici report 6-year follow-up data for Glybera
Read More
Amorfix and Trellis Bioscience to collaborate on anti-CD38 cancer treatment
Read More
Cardium Therapeutics changes name to Taxus Cardium Pharmaceuticals
Read More
MD Anderson and MedImmune collaborate on cancer immunotherapy
Read More
ATL-1102 studied in phase I stem cell mobilization study
Read More
Resolve Therapeutics initiates clinical development of RSLV-132 for SLE
Read More
FDA approves Hemangeol for infantile hemangioma
Read More
FDA clears Summit to begin phase II study of SMT-19969 in C. difficile infection
Read More
SillaJen completes acquisition of Jennerex
Read More